Skip to Main Content

Author Details

Nuria Montserrat
Catalan Institution for Research and Advanced Studies (ICREA)
2004
93
39
PMIDPaper TitleJournal TitlePublished Year
36964318Direct reprogramming of human fibroblasts into insulin-producing cells using transcription factors.Commun Biol2023
34781071Dissecting nephron morphogenesis using kidney organoids from human pluripotent stem cells.Curr Opin Genet Dev2022
35856020Fine-tuned KDM1A alternative splicing regulates human cardiomyogenesis through an enzymatic-independent mechanism.iScience2022
35781796Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.EMBO Mol Med2022
35623327Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity.Cell2022
35561674A diabetic milieu increases ACE2 expression and cellular susceptibility to SARS-CoV-2 infections in human kidney organoids and patient cells.Cell Metab2022
36595951Protocol for SARS-CoV-2 infection of kidney organoids derived from human pluripotent stem cells.STAR Protoc2022
36177947Engineering multicellular living systems-a Keystone Symposia report.Ann N Y Acad Sci2022
36120564Assessing kidney development and disease using kidney organoids and CRISPR engineering.Front Cell Dev Biol2022
35274072Principles for the design of multicellular engineered living systems.APL Bioeng2022
33179852Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.EMBO Mol Med2021
33763892Task force groups of Transplant International: working together to globally connect the transplant community of tomorrow.Transpl Int2021
33846613Addendum: Active superelasticity in three-dimensional epithelia of controlled shape.Nature2021
34876199Development of a new score for early mortality prediction in trauma ICU patients: RETRASCORE.Crit Care2021
34545368Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.bioRxiv2021
34448274T- and B-cell therapy in solid organ transplantation: current evidence and future expectations.Transpl Int2021
34448263Mini-organs forum: how to advance organoid technology to organ transplant community.Transpl Int2021
34442810The New Generation <i>h</i>DHODH Inhibitor MEDS433 Hinders the In Vitro Replication of SARS-CoV-2 and Other Human Coronaviruses.Microorganisms2021
34048692ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.Stem Cell Reports2021
33199860Rethinking organoid technology through bioengineering.Nat Mater2021
33301705The Nuclear Receptor ESRRA Protects from Kidney Disease by Coupling Metabolism and Differentiation.Cell Metab2021
32492887Transplantation Induces Profound Changes in the Transcriptional Asset of Hematopoietic Stem Cells: Identification of Specific Signatures Using Machine Learning Techniques.J Clin Med2020
31740253Bioelectronic Recordings of Cardiomyocytes with Accumulation Mode Electrolyte Gated Organic Field Effect Transistors.Biosens Bioelectron2020
32034376Author Correction: Conversion of human fibroblasts to angioblast-like progenitor cells.Nat Methods2020
33062328Dermatological Manifestations in the Intensive Care Unit: A Practical Approach.Crit Care Res Pract2020
33081694Machine learning techniques for mortality prediction in critical traumatic patients: anatomic and physiologic variables from the RETRAUCI study.BMC Med Res Methodol2020
33131609Human recombinant soluble ACE2 in severe COVID-19.Lancet Respir Med2020
32989249Global hyperactivation of enhancers stabilizes human and mouse naive pluripotency through inhibition of CDK8/19 Mediator kinases.Nat Cell Biol2020
32333836Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2.Cell2020
32237237The emergence of regenerative medicine in organ transplantation: 1st European Cell Therapy and Organ Regeneration Section meeting.Transpl Int2020
29398167Severity scores in trauma patients admitted to ICU. Physiological and anatomic models.Med Intensiva (Engl Ed)2019
31158828Multi-cellular engineered living systems: building a community around responsible research on emergence.Biofabrication2019
30778227Fine tuning the extracellular environment accelerates the derivation of kidney organoids from human pluripotent stem cells.Nat Mater2019
31118076A prospective pilot study using metabolomics discloses specific fatty acid, catecholamine and tryptophan metabolic pathways as possible predictors for a negative outcome after severe trauma.Scand J Trauma Resusc Emerg Med2019
28988229Studying Kidney Disease Using Tissue and Genome Engineering in Human Pluripotent Stem Cells.Nephron2018
30053940Forty years of IVF.Fertil Steril2018
29976689At the Heart of Genome Editing and Cardiovascular Diseases.Circ Res2018
30401836Active superelasticity in three-dimensional epithelia of controlled shape.Nature2018
30459215Modeling epigenetic modifications in renal development and disease with organoids and genome editing.Dis Model Mech2018
30308018Location-dependent effects of trauma on oxidative stress in humans.PLoS One2018
29564204Roadblocks in the Path of iPSC to the Clinic.Curr Transplant Rep2018
29560089Kidney organoids for disease modeling.Oncotarget2018
30159426Non-coding microRNAs for cardiac regeneration: Exploring novel alternatives to induce heart healing.Noncoding RNA Res2017
26938311Regenerative strategies for kidney engineering.FEBS J2016
28066778Genome editing in human pluripotent stem cells: a systematic approach unrevealing pancreas development and disease.Stem Cell Investig2016
27300161Characterization of the Epigenetic Changes During Human Gonadal Primordial Germ Cells Reprogramming.Stem Cells2016
27179434Myocardial commitment from human pluripotent stem cells: Rapid production of human heart grafts.Biomaterials2016
26688542Contribution of in vitro myocytes studies to understanding fish muscle physiology.Comp Biochem Physiol B Biochem Mol Biol2016
24612759[Severe complications of orotracheal intubation in the Intensive Care Unit: An observational study and analysis of risk factors].Med Intensiva2015
26294212Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis.Cancer Res2015
  • 1 - 50 of 93

Recommended Authors

John Antonydas Gaspar
Research Centre, Ananda College
Career Start Year 2010
Number of shared co-authors 0
Alejandro De Los Angeles
Massachusetts Institute of Technology
Career Start Year 2008
Number of shared co-authors 5
Jizhong Zou
and Blood Institute, National Institutes of Health
Career Start Year 2008
Number of shared co-authors 2
Nelly M Cruz
Memorial Sloan Kettering Cancer Center
Career Start Year 2005
Number of shared co-authors 0
Johannes Winkler
Medical University of Vienna
Career Start Year 2005
Number of shared co-authors 0
Vittorio Sebastiano
Stanford University
Career Start Year 2004
Number of shared co-authors 2
Michael Xavier Doss
BioMarin Pharmaceutical Inc.
Career Start Year 2003
Number of shared co-authors 0
Kurt Pfannkuche
University Clinics of Cologne
Career Start Year 2002
Number of shared co-authors 0
Guokai Chen
University of Macau
Career Start Year 2002
Number of shared co-authors 1
In-Hyun Park
Yale School of Medicine
Career Start Year 2002
Number of shared co-authors 8
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Career Start Year 2000
Number of shared co-authors 4
Yoon-Young Jang
Daegu Catholic University Medical Center, Catholic University of Daegu
Career Start Year 1999
Number of shared co-authors 0
Xianmin Zeng
College of Food Science and Technology, Nanjing Agricultural University
Career Start Year 1999
Number of shared co-authors 1
Bin Zhou
The Central Hospital of Shaoyang
Career Start Year 1998
Number of shared co-authors 0
Paolo Cinelli
Zurich University Hospital
Career Start Year 1997
Number of shared co-authors 0
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year 1996
Number of shared co-authors 2
Jeanette Beers
and Blood Institute, National Institutes of Health
Career Start Year 1996
Number of shared co-authors 0
Robert Passier
University of Twente
Career Start Year 1995
Number of shared co-authors 3
Dmitry A Ovchinnikov
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 1
Benjamin D Humphreys
Washington University in St. Louis School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Michael And??ng
Karolinska Institutet
Career Start Year 1994
Number of shared co-authors 0
Reza Ardehali
University of California los angeles
Career Start Year 1993
Number of shared co-authors 3
Daisuke Sugiyama
Translational Research Center, Hiroshima University
Career Start Year 1992
Number of shared co-authors 1
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year 1992
Number of shared co-authors 1
Fabio M V Rossi
University of British Columbia
Career Start Year 1990
Number of shared co-authors 3
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Career Start Year 1990
Number of shared co-authors 16
William L Stanford
Ottawa Hospital Research Institute
Career Start Year 1989
Number of shared co-authors 2
Linzhao Cheng
Johns Hopkins University School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Career Start Year 1987
Number of shared co-authors 1
Daniel J Garry
University of Minnesota
Career Start Year 1986
Number of shared co-authors 1

Collaborators

Juan Carlos Izpisua Belmonte
Inc., Salk Institute for Biological Studies
Co-authored papers 43
Kun Zhang
China Pharmaceutical University
Co-authored papers 6
Christopher Benner
Michigan State University College of Human Medicine
Co-authored papers 4
Nongluk Plongthongkum
King Mongkut's University of Technology Thonburi
Co-authored papers 4
Insoo Hyun
Center for Bioethics, Harvard Medical School
Co-authored papers 3
Ho-Lim Fung
Co-authored papers 3
Athurva Gore
Co-authored papers 3
Ian Crozier
Christchurch Hospital
Co-authored papers 2
Rathi D Thiagarajan
Co-authored papers 2
John R Yates
TheScripps Research Institute
Co-authored papers 2
George Q Daley
Boston Children's Hospital, Harvard Medical School
Co-authored papers 2
Robert H Shoemaker
National Cancer Institute
Co-authored papers 2
Magdalena Zernicka-Goetz
California Institute of Technology, USA. institute of technology.edu.
Co-authored papers 1
Jun Takahashi
Center for iPS Cell Research and Application, Kyoto University
Co-authored papers 1
Steven A Goldman
Center for Translational Neuromedicine, University of Rochester Medical Center
Co-authored papers 1
Junying Yu
Co-authored papers 1
Liming Pei
Co-authored papers 1
Ali H Brivanlou
the Rockefeller University
Co-authored papers 1
Jeffrey P Kahn
Berman Institute of Bioethics, Johns Hopkins University
Co-authored papers 1
Yali Cong
Department of Medical Ethics and Law, Peking University Health Science Center
Co-authored papers 1
Kazuto Kato
Osaka University
Co-authored papers 1
Junhyong Kim
Co-authored papers 1
Michael Murphy
Co-authored papers 1
Francisco Fern??ndez-Avil??s
Gregorio Maranon University Hospital
Co-authored papers 1
Amander T Clark
Center for Reproductive Science, University of California los angeles
Co-authored papers 1
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Co-authored papers 1
Ulrich Wagner
Co-authored papers 1
Neri Laufer
Hadassah Medical Center, Hebrew University of Jerusalem Faculty of Medicine.
Co-authored papers 1
Todd C McDevitt
Gladstone Institute of Cardiovascular Disease
Co-authored papers 1
Mitinori Saitou
Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University
Co-authored papers 1
Release 1.2